QA: Tempest Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001544227_2022_Tempest_Therapeutics_Inc.pdf

Logs

warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001544227', 'EntityCommonStockSharesOutstanding': 7173094, 'Assets': 73238000, 'AssetsCurrent': 68963000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 37121000, 'LiabilitiesAndStockholdersEquity': 73238000, 'LiabilitiesCurrent': 20026000, 'LiabilitiesNoncurrent': 17095000, 'NetIncome': -28302000, 'PropertyPlantAndEquipmentNet': 1113000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 3162000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_NetIncome': -28302000, 'remainder_Revenues': 0, 'remainder_StockholdersEquity': 36117000, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001544227')"}

Edgar->Model Mapping